Mini-Oral Session

[MO26] Mini-Oral Session 26　Head and Neck Cancer 1（Clinical Practice & Basic Practice）
【E】

Fri. Feb 18, 2022 10:00 AM - 10:50 AM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Shigenori Kadowaki（Department of Clinical Oncology, Aichi Cancer Center Hospital），Yoshitaka Honma（Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital）

+Add all to schedule

[MO26-1] miR-21 and miR-184 as early diagnostic miRs for oral squamous cell carcinomas and oral potentially malignant disorders

^○Aarushi Garg¹, Sameer A Guru², Bhidhan C Koner³, Augstine J¹, Aadithya B Urs¹ (1.Department of oral pathology and microbiology, Maulana Azad Institute of Dental Sciences, 2.Department of Developmental and Systems Biology, Lurie Children's Hospital, Northwestern University, Chicago, Illinois, USA, 3.Department of Biochemistry, Maulana Azad Medical College, New Delhi, India)

[MO26-2] Intra-tumoral clusters between CD20+ B cells and BCL6+ CD4+ T cells are prognostic in early oral cancers

^○Chumut Phathunane^1,3, Rebecca Wijers², Maria De Herdt³, Senada Koljenovic³, Stefan Sleijfer², Robert Baatenburg De Jong³, Jose Hardillo³, Reno Debets², Hayri Emrah Balcioglu² (1.Department of Medical Oncology, HRH Princess Chulabhorn College of Medical Science, 2.Department of Medical Oncology, Erasmus MC Cancer Institute, 3.Departments of Otorhinolaryngology, Erasmus MC Cancer Institute)

[MO26-3] miR-155-5p and miR-1246 as promising biomarkers in oral squamous cell carcinomas

^○Maheswari Ramamoorthy¹, Sameer A Guru², Bhidhan C Koner³, Priya Kumar¹, Aadithya B Urs¹ (1.Department of Oral Pathology, Maulana Azad Institute of Dental Sciences, New Delhi 110002, India, 2.Department of Developmental and Systems Biology, Lurie Children's Hospital, Northwestern University, Chicago, Illinois, USA, 3.Department of Biochemistry, Maulana Azad Medical College, New Delhi, India)

[MO26-4] The relationship between PD-L1 expression and therapeutic effect of anti-PD-1 antibody in head and neck cancers

^○Akihiro Ohara¹, Taisuke Mori², Mai Itoyama¹, Kazuki Yokoyama¹, Shun Yamamoto¹, Ken Kato¹, Yoshitaka Honma¹ (1.Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 2.Department of Diagnostic Pathology, National Cancer Center Hospital)

[MO26-5] Retrospective Analysis of Pembrolizumab Alone or with Chemotherapy for Recurrent or Metastatic Head and Neck Cancer

^○Jun Taguchi, Yasushi Shimizu, Akihiko Shiiya, Shin Ariga, Tomohiro Goda, Yoshihito Ohhara, Takuro Noguchi, Satoshi Takeuchi, Ichiro Kinoshita, Hirotoshi Akita (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University)

[MO26-6] Short-term outcomes of induction chemotherapy followed by chemoradiotherapy in locally advanced sinonasal carcinoma

^○Mai Itoyama¹, Akihiro Ohara¹, Kazuki Yokoyama¹, Shun Yamamoto¹, Ken Kato¹, Tairo Kashihara², Naoya Murakami², Hiroshi Igaki², Yoshifumi Matsumoto³, Go Omura³, Seiichi Yoshimoto³, Taisuke Mori⁴, Yoshitaka Honma¹ (1.Department of Head&Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 2.Department of Radiation Oncology, National Cancer Center Hospital, 3.Department of Head and Neck Surgery, National Cancer Center Hospital, 4.Department of Diagnostic Pathology, National Cancer Center Hospital)